Drugs / Progesterone in oil
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00805935 | Jan 2009 → Jul 2010 | infertility disorder, polycystic ovary syndrome | Ferring Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Progesterone in oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00805935 ↗ |
| Known as | PIO | “This report describes the administration preferences expressed by women with infertility that were given progesterone vaginal insert (PVI) or progesterone in oil injections...” PMID 25385669 ↗ Nov 2014 |
| Route | Intramuscular | “50 mg by intramuscular injection once per day, starting on the day after oocyte retrieval until 10 weeks gestation or confirmation of negative pregnancy test.” NCT00805935 ↗ |